The combination of bispecific antibody CTX-009 and chemotherapy received Fast Track Designation for advanced, previously treated biliary tract cancers.
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 05, 2024 HUTCHMED Limited today announces that new and updated data from several studies of compounds discovered by HUTCHMED will.
HUTCHMED Highlights Data to be Presented at AACR Congress 2024 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Provider and patient perspectives on why patient education about FGFRi treatment-associated adverse events and how to manage them are is essential in helping patients maintain a good quality of life and stay on treatment.